Guide
Medication-Assisted Treatment: Fact vs Fiction
Medication for opioid and alcohol use disorder is the most effective treatment addiction medicine has, and the most argued about. Most of the arguments are twenty years old. Here are the nine objections you will hear, and what the evidence says about each.
Fiction: it is trading one addiction for another
Fact: addiction is compulsive use despite harm. A person taking a stable daily dose of buprenorphine or methadone from a prescriber, going to work, and not overdosing is not compulsively using anything. They are physically dependent on a medication, the way a person with diabetes depends on insulin or a person with high blood pressure depends on their pill. The two ideas get confused because both involve daily dosing. The outcomes could not be more different: in a pooled analysis of cohort studies, all-cause mortality roughly halved while people with opioid use disorder were on buprenorphine or methadone.
Fiction: you are not really sober on it
Fact: this is a definition, not a finding. Every major medical body, including the American Society of Addiction Medicine and the National Institute on Drug Abuse, considers a person in treatment with medication to be in recovery. Some mutual-support groups disagree, and people on medication sometimes feel unwelcome in certain meetings. That is a reason to find a different meeting, not a reason to stop a medication that is keeping you alive.
Fiction: Suboxone gets you high, so it is just another drug
Fact: buprenorphine is a partial agonist with a ceiling effect. At treatment doses in a person with opioid tolerance it produces no high; it stops withdrawal and craving. It is diverted and sold, mostly to people who use it to avoid withdrawal when they cannot get treatment, which is an argument for more access, not less.
Fiction: methadone is for people who have given up
Fact: methadone has the longest track record of any addiction medication and often holds better than buprenorphine for people with heavy or long fentanyl use. The daily visit to a licensed program is a real burden, and it is the reason many people choose buprenorphine instead. That is a logistics choice, not a moral one. Federal rules loosened in 2024 to allow more take-home doses sooner.
Fiction: naltrexone is the clean one
Fact: naltrexone (Vivitrol) is a good option for some people, particularly for alcohol use disorder, and it has the appeal of no opioid effect and a monthly injection. It also requires seven to ten days fully opioid-free before the first dose, which many people cannot get through, and the evidence for preventing overdose death is weaker than for buprenorphine and methadone. It is one tool, not the clean one.
Fiction: you have to detox before starting
Fact: for buprenorphine and methadone, you do not. Buprenorphine is started in early withdrawal, usually 12 to 24 hours after last use, and methadone is started at a licensed program without any detox at all. Only naltrexone requires a period off opioids first. Many New Jersey emergency departments start buprenorphine the same day.
Fiction: you should get off it as soon as possible
Fact: there is no clinical reason to taper on a calendar, and the data on early discontinuation are grim: overdose risk rises sharply in the weeks after stopping, because tolerance falls while the world does not change. People who stay on medication for a year or more do better than people who stop at three months. If you want to come off eventually, the time is after long stability, slowly, with your prescriber, and never because someone else decided it was time.
Fiction: insurance will not cover it, or makes you jump through hoops
Fact: in New Jersey, NJ FamilyCare covers buprenorphine, methadone, and naltrexone without prior authorization, and state-regulated commercial plans are barred from requiring prior authorization for medications used to treat substance use disorder under the 2017 law. If a pharmacy reports a block, it is usually a formulary preference for a generic, not a denial. Our parity guide explains which plans the law covers.
Fiction: a good program does not need medication
Fact: a program that refuses to offer medication for opioid use disorder is practicing below the standard of care, whatever its philosophy. Counseling, housing, and community matter enormously, and they work better alongside medication than instead of it. When you are choosing a program, this is one of the ten questions worth asking first.
The short version. Medication is not the whole of treatment, and it is not a moral failing. It is the part of treatment with the strongest evidence for reducing deaths, which buys the time the rest of treatment needs to work. Our MAT treatment guide covers how to start in New Jersey this week.
Need help finding detox? Call the admissions line of our publisher, Periscope Behavioral Health: (888) 313-3583. Confidential, and insurance questions are welcome. Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777.
Frequently asked
- Is Suboxone just replacing one addiction with another?
- No. Addiction is compulsive use despite harm. A stable prescribed dose of buprenorphine stops withdrawal and craving without producing a high, and roughly halves the risk of overdose death. Physical dependence on a prescribed medication is not addiction.
- How long should someone stay on Suboxone or methadone?
- As long as it is working. There is no clinical reason to taper on a schedule, and stopping early sharply raises overdose risk. People who stay in treatment with medication for a year or more do better than those who stop at three months.
- Do you have to detox before starting MAT?
- Not for buprenorphine or methadone. Buprenorphine is started in early withdrawal and methadone at a licensed program without detox. Only naltrexone (Vivitrol) requires about seven to ten days opioid-free first.
- Does NJ Medicaid cover Suboxone?
- Yes, without prior authorization, along with methadone and naltrexone. State-regulated commercial plans in New Jersey are also barred from requiring prior authorization for substance use disorder medications.
Need to talk to someone?
Request confidential help — 24/7, no obligation.
Tell us about your situation and a DetoxNJ care navigator will reach out. DetoxNJ is published by Periscope Behavioral Health, which operates or holds an ownership interest in Emerald Wellness, South Jersey Recovery Program, Palm Beach Recovery Centers, Palm Beach Healing Centers, and Transitions Recovery Program, and is developing a medical detox in Hammonton, NJ (expected Summer 2027). We make an introduction only if you ask us to.
Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777